Fintepla Dosage
Generic name: fenfluramine (oral solution)
Drug classes: CNS stimulants, Miscellaneous anticonvulsants
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: SOL: 2.2 mg per mL
Restricted Distribution in US
Seizures, Dravet syndrome
- [w/o stiripentol]
- Dose: 0.1-0.35 mg/kg/dose PO bid; Start: 0.1 mg/kg/dose PO bid x6 days, then may incr. to 0.2 mg/kg/dose PO bid x7 days, then may incr. to 0.35 mg/kg/dose PO bid; Max: 0.35 mg/kg/dose, 26 mg/day; Info: may incr. dose q4 days if more rapid titration needed; taper dose gradually to D/C
- [w/ stiripentol and clobazam]
- Dose: 0.1-0.2 mg/kg/dose PO bid; Start: 0.1 mg/kg/dose PO bid x6 days, then may incr. to 0.15 mg/kg/dose PO bid x7 days, then may incr. to 0.2 mg/kg/dose PO bid; Max: 0.2 mg/kg/dose, 17 mg/day; Info: taper dose gradually to D/C
Seizures, Lennox-Gastaut syndrome
- [w/o stiripentol]
- Dose: 0.35 mg/kg/dose PO bid; Start: 0.1 mg/kg/dose PO bid x6 days, then incr. to 0.2 mg/kg/dose PO bid x7 days, then incr. to 0.35 mg/kg/dose PO bid; Max: 26 mg/day; Info: may incr. dose q4 days if more rapid titration needed; taper dose gradually to D/C
- [w/ stiripentol and clobazam]
- Dose: 0.2 mg/kg/dose PO bid; Start: 0.1 mg/kg/dose PO bid x6 days, then incr. to 0.15 mg/kg/dose PO bid x7 days, then incr. to 0.2 mg/kg/dose PO bid; Max: 17 mg/day; Info: taper dose gradually to D/C
Renal dosing
- [w/o stiripentol]
- eGFR >30: not defined; eGFR 15-29: max 20 mg/day; eGFR <15: not defined
- HD/PD: not defined
- [w/ stiripentol and clobazam]
- eGFR >30: not defined; eGFR 15-29: max 17 mg/day; eGFR <15: not defined
- HD/PD: not defined
Hepatic dosing
- hepatic impairment: avoid use
SRC: NLM .